Nayneshkumar Patel
Critical Care Medicine · Hot Springs, ARNPI 1154539807
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.6% of the total across 551 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 18.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,252, 2.3 times the $977 reported in 2019. Among critical care medicine clinicians in AR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 551 payments — averaging $18.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$2K
- AstraZeneca$2K
- Boehringer Ingelheim$997
- Mallinckrodt Hospital Products Inc.$894
- Actelion Pharmaceuticals US, Inc.$548
- Regeneron Healthcare Solutions, Inc.$528
- plus $4K from 32 others
What the payments were for
- Food & beverage$9,95896%
- Education$4544%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 138 | $1,944 |
| AstraZeneca | 89 | $1,689 |
| Boehringer Ingelheim | 51 | $997 |
| Mallinckrodt Hospital Products Inc. | 36 | $894 |
| Actelion Pharmaceuticals US, Inc. | 21 | $548 |
| Regeneron Healthcare Solutions, Inc. | 24 | $528 |
| Sanofi | 23 | $476 |
| Grifols USA, LLC | 24 | $458 |
| Mylan Specialty L.p. | 20 | $367 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $228 |
| United Therapeutics Corporation | 6 | $210 |
| Paratek Pharmaceuticals, Inc. | 10 | $198 |
| Viatris Specialty LLC | 9 | $169 |
| Amgen | 3 | $162 |
| Verona Pharma, Inc. | 9 | $155 |
| Mallinckrodt Enterprises LLC | 6 | $136 |
| Insmed, Inc. | 7 | $128 |
| Electromed, Inc. | 8 | $126 |
| E.r. Squibb & Sons, L.L.C. | 9 | $124 |
| Philips North America LLC | 6 | $120 |
| Baxter Healthcare | 6 | $108 |
| Vifor Pharma, Inc. | 4 | $83 |
| Sunovion Pharmaceuticals Inc. | 5 | $77 |
| Genentech USA, Inc. | 5 | $74 |
| Sanofi-aventis U.S. LLC | 1 | $67 |
| Advanced Respiratory, Inc | 4 | $60 |
| Shire North American Group Inc | 3 | $56 |
| AbbVie(2 entities) | 2 | $43 |
| Ceribell, Inc. | 1 | $38 |
| Novartis | 1 | $24 |
| ANI Pharmaceuticals, Inc. | 1 | $21 |
| Bayer | 1 | $19 |
| Circassia Inc. | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Monaghan Medical Corporation | 1 | $16 |
| Johnson & Johnson | 1 | $14 |
| Liquidia Technologies, Inc. | 1 | $14 |
| Inogen, Inc. | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,412 in reported general payments places this provider in the 95th percentile of 30 critical care medicine providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ActharCorticotropin | 12 | $538,179 |
| OfevNintedanib Esylate | 23 | $300,695 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 391 | $270,206 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 154 | $82,732 |
| NucalaMepolizumab | 12 | $43,316 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 61 | $42,280 |
| Spiriva HandihalerTiotropium Bromide | 32 | $25,135 |
| Breo ElliptaFluticasone/Vilanterol | 46 | $22,657 |
| SymbicortBudesonide/Formoterol Fumarate | 54 | $18,133 |
| Spiriva RespimatTiotropium Bromide | 32 | $16,114 |
| Incruse ElliptaUmeclidinium Bromide | 35 | $13,557 |
| Advair HfaFluticasone Propion/Salmeterol | 29 | $12,981 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 18 | $11,168 |
| Roflumilast | 71 | $9,135 |
| Atrovent HfaIpratropium Bromide | 13 | $6,089 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Mallinckrodt Hospital Products Inc.Acthar | $894 | $538,17912 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Nucala, Breo Ellipta, Incruse Ellipta | $1,944 | $432,468638 claims |
| Boehringer IngelheimOfev, Spiriva Respimat, Combivent Respimat | $997 | $327,97873 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $1,689 | $60,414115 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 30 critical care medicine providers in Arkansas.
Other critical care medicine in Hot Springs
- Syed MustafaHot Springs$5K
- Jaydon PetersonHot Springs$2K
- Christopher JohnLittle Rock$8K
- Muthukumar RadhakrishnanFort Smith$7K
- Megan RashidLittle Rock$3K
- Cidney HulettLittle Rock$2K
- Aashish NeupaneFort Smith$2K
- Muhammad JaffarLittle Rock$1K
- Amr IsmailConway$1K
- Mohankumar DoraiswamyFort Smith$800
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.